Product description: the main component of this product is peimetrazate disodium.

Molecular weight: 525.43

Auxiliary material: Mannitol.

1. Non-small cell lung cancer: This drug is applicable to the treatment ofpatients with advanced or metastatic non-squamous cell lung cancer patients whohave received first-line chemotherapy. This product is not recommended forpatients with squamous cell carcinoma.

2.Malignant pleural mesothelioma: With combination of cisplatin, the product canbe used for malignant pleural mesothelioma patients that cannot receivesurgical treatment.

This product must be used under the guidance ofqualified physicians with experience of anti-tumor chemotherapy. This productis only applicable for intravenous injection, and the formulation of itssolution must be carried out in accordance with the preparation instruction of intravenous solution.